Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LAB · against 298 other Healthcare companies of similar size
Ranked #73 of 299 · scores higher than 76% of peers · safety percentile 81
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)37 peers with a safety percentile of 80–89, including LAB · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | LAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 269 reported | 0.05× | 0.19× | 71% | 33% | |
| BetaLower is better · 284 reported | 1.35 | 0.51 | 15% | 33% | |
| Current ratioHigher is better · 295 reported | 9.10× | 3.14× | 81% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 165M USD | 99 | 50 | |
| 4 | 261M USD | 99 | 97 | |
| 5 | 397M USD | 99 | 37 | |
| 69 | 2.5B CNY (≈$346M) | 82 | 45 | |
| 70 | 298M CHF (≈$342M) | 82 | 74 | |
| 71 | 2.8B CNY (≈$396M) | 81 | 29 | |
| 72 | 3.0B CNY (≈$415M) | 81 | 55 | |
| 73 | 239M USD | 81 | 38 | |
| 74 | 418M USD | 81 | 74 | |
| 75 | 186M USD | 81 | 43 | |
| 76 | 63.5B JPY (≈$432M) | 81 | 57 | |
| 77 | 264M USD | 81 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score